Search Login Register

Lepromatous Leprosy Summary

Description: A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.

Also Known As: Leprosy, Lepromatous; Cutaneous Leprosies; Cutaneous Leprosy; Lepromatous Leprosies; Leprosies, Cutaneous Show All >>

Networked: 853 relevant articles (21 outcomes, 84 trials/studies) for this Disease

Key Drugs and Agents for Lepromatous Leprosy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Dapsone : 2 outcomes 12 studies in 69 results : FDA 3
  2. Immunoglobulin M (IgM) : 2 outcomes 1 study in 23 results : IBA
  3. Vaccines : 2 outcomes in 3 results : IBA
  4. Rifampin (Rifampicin) : 1 outcome 7 studies in 46 results : FDA 13 Generic
  5. Clofazimine (Lamprene) : 1 outcome 6 studies in 44 results : FDA 1
  6. Antibodies : 1 outcome 3 studies in 53 results : IBA
  7. Immunoglobulin G (IgG) : 1 outcome 3 studies in 31 results : IBA
  8. Levamisole (Decaris) : 1 outcome 3 studies in 7 results : FDA 1
  9. Thalidomide (Thalomid) : 1 outcome 2 studies in 29 results : FDA 2
  10. Lepromin : 1 outcome 2 studies in 27 results : IBA
Show All >>

Diseases Related to Lepromatous Leprosy

  1. Leprosy (Hansen's Disease)
  2. Hypersensitivity (Allergy)
  3. Erythema Nodosum
  4. Multibacillary Leprosy
  5. Infection
Show All >>

Key Therapies for Lepromatous Leprosy

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome 3 studies in 30 results
  2. Immunotherapy : 1 outcome 3 studies in 12 results
  3. Aftercare (After-Treatment) : 1 outcome in 7 results
  4. Transplants (Transplant) : 1 outcome in 4 results
  5. Homologous Transplantation (Allograft) : 1 study in 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.